Lakey, L, Chandaria, K, Quince, C, Kane, M, Saunders, T.
Dementia 2012: A National Challenge. Alzheimer's Society, 2012.
Banerjee, S, Wittenberg, R.
Clinical and cost effectiveness of services for early diagnosis and intervention in dementia. Int J Geriat Psychiatry
2009; 24: 748–54.
Waldemar, G, Dubois, B, Emre, M, Georges, J, McKeith, IG, Rossor, M, et al. Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol
2007; 14: e1–26.
National Institute for Health and Clinical Excellence. Dementia: Supporting People with Dementia and Their Carers in Health and Social Care (Clinical Guidance CG42). NICE, 2006.
Hort, J, O'Brien, T, Gainotti, G, Pirttila, T, Popescu, BO, Rektorova, I, et al. EFNS guidelines for the diagnosis and management of Alzheimer's disease. Eur J Neurol
2010; 17: 1236–48.
Clarfield, AM. The decreasing prevalence of reversible dementias: an updated meta-analysis. Arch Intern Med
2003; 163: 2219–29.
Hejl, AM, Hogh, P, Waldemar, G.
Potentially reversible conditions in 1000 consecutive memory clinic patients. J Neurol Neurosurg Psychiatry
2002; 73: 390–4.
Gifford, DR, Holloway, RG, Vickery, BG. Systematic review of clinical prediction rules for neuroimaging in the evaluation of dementia. Arch Intern Med
2000; 160: 2855–62.
Jack, CR Jr, Petersen, RC, O'Brien, PC, Tangalos, EG. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology
1992; 42: 183–8.
de Leon, MJ, George, AE, Stylopoulos, LA, Smith, G, Miller, DC. Early marker for Alzheimer's disease: the atrophic hippocampus. Lancet
1989; 2: 672–3.
McKhann, GM, Knopman, DS, Chertkow, H, Hyman, BT, Jack, CR, Kawas, CH, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement
2011; 7: 263–9.
Scheltens, P, Fox, N, Barkhof, N, De Carli, C.
Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion. Lancet Neurol
2002; 1: 13–21.
Roman, GC, Tatemichi, TK, Erkinjutti, T, Cummings, JL, Masden, JC, Garcia, JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology
1994; 43: 250–60.
McKeith, IG, O'Brien, J, Walker, Z, Tatsch, K, Booij, J, Darcourt, J, et al. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol
2007; 6: 305–13.
McKeith, IG, Dickson, DW, Lowe, J, Emre, M, O'Brien, JT, Feldman, H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology
2005; 65: 1863–72.
Rascovsky, K, Hodges, JR, Knopman, D, Mendez, MF, Kramer, JH, Neuhaus, J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain
2011; 134 (Pt 9): 2456–77.
Imaging in Alzheimer's disease. Dialogues Clin Neurosci
2009; 11: 191–9.
Karas, G, Scheltens, P, Rombouts, S, van Schijndel, R, Klein, M, Jones, B, et al. Precuneus atrophy in early-onset Alzheimer's disease: a morphometrical structural MRI study. Neuroradiology
2007; 49: 967–76.
Wattjes, MP, Henneman, WJ, van der Flier, WM, de Vries, O, Traber, F, Geurts, JJ, et al. Diagnostic imaging of patients in a memory clinic: comparison of MR imaging and 64-detector row CT. Radiology
2009; 253: 174–86.
Department of Health. NHS Reference Costs 2009–2010. Department of Health, 2011.